Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia

Overview of attention for article published in Leukemia, November 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (89th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

twitter: 22 X users

patent: 2 patents

Citations

dimensions_citation: 66 Dimensions

Readers on

mendeley: 88 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 22 X posts from 22 X users, with an upper bound of 67,294 followers.

Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia. https://t.co/4KL9K4D3yK

03 Sep 2020

Reply Repost Favourite

RT @aljurf100: Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy o…

03 Apr 2020

Reply Repost Favourite

Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy of B-cell precursor acute lymphoblastic leukemia https://t.co/ULgdw9bEUH

02 Apr 2020

Reply Repost Favourite

RT @CARTTherapy: Efficacy of third-party chimeric antigen receptor modified peripheral blood natural killer cells for adoptive cell therapy…

27 Dec 2019

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 18 additional X posts.